NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: D
Post# of 188
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, will be providing its digital therapeutics solution to qualified employees of a U.S.-based Fortune 500 technology company. The contract, which goes into effect on Jan. 1, 2021, with the beginning of a new benefits year, calls for Dario to provide its digital diabetes tools and coaching to employees and their dependents. “We believe that employees will benefit from Dario’s unique therapeutic approach, which delivers adaptive, personalized experiences designed to drive behavior change through intuitive, clinically proven digital tools and coaching,” said DarioHealth president and North America GM Rick Anderson in the press release. “These employees will join a community of tens of thousands of members who engage with Dario every day to measurably improve their health. This contract was awarded through a request for proposal (“RFP”) process that included Dario’s largest competitors, and we believe it represents an important milestone in our strategic shift toward the business-to-business-to-consumer (“B2B2C”) market comprised of self-insured employers, healthcare provider networks, and insurance plans. We believe this further validates the competitive strength of our top-rated digital chronic care solution and will serve as an important market reference in converting our employer pipeline.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer